Literature DB >> 32715475

Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.

Qirong Geng1,2, Jiawen Lao3,4, Xiaoyu Zuo4, Shangxiang Chen3,4, Jin-Xin Bei4, Dazhi Xu2,5.   

Abstract

Rates of gastroesophageal junction adenocarcinomas (GEJAs) have shown an alarming increase; however, the genetic background of GEJA and its Siewert classification have yet to be uncovered. Here, 60 paired tumor and normal DNA samples from GEJA patients were analyzed by whole-exome sequencing. Among them, 13 were Siewert type I, 14 were type II, and 33 were type III. A predominance of C/G>T/A substitutions was discovered in GEJA, followed by C/G>A/T substitutions. Notably, Siewert type I and type II/III display distinct sets of driver genes, mutational spectrum, and recurrently disrupted pathways. Siewert type I showed similarity to esophageal adenocarcinomas (EACs) and the chromosomal instability subtype of stomach adenocarcinomas, while Siewert type II/III showed similarity to the genomic stable subtype of stomach adenocarcinoma. We also found that mutation of FBXW7, a driver gene of GEJA, was enriched in Siewert type I. Our data identify differences between GEJA and stomach/EACs at the genomic level and provide evidence for differential treatment based on Siewert classification of GEJA.
© 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  FBXW7; Siewert classification; esophageal adenocarcinoma; gastric cancer; gastroesophageal junction; genomic features; whole-exome

Year:  2020        PMID: 32715475     DOI: 10.1002/path.5516

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  2 in total

1.  Surgical pathology of adenocarcinomas arising around or within the gastroesophageal junction.

Authors:  Bastian Dislich; Dino Kröll; Rupert Langer
Journal:  Updates Surg       Date:  2022-08-24

2.  Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.

Authors:  Jian Chen; Yu-Jian Xia; Tian-Yu Liu; Yuan-Hui Lai; Ji-Shang Yu; Tian-Hao Zhang; Shiyin Ooi; Yu-Long He
Journal:  BMC Cancer       Date:  2021-05-10       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.